Beast Ventures

Beast Ventures is a venture capital firm based in London, focusing on early-stage investments in deep tech and transformative technologies. Established in 2015, Beast Ventures targets startups across the UK and Continental Europe that are working on breakthrough engineering, applied science, and technology (hence the acronym BEAST). The firm emphasizes investments in frontier technologies that hold the potential for significant impact in areas such as health, climate, and society. Beast Ventures typically invests at the seed stage, providing support to founders from the inception of their companies through various stages of growth. The firm’s investment portfolio spans diverse industries including artificial intelligence, biotech, cybersecurity, climate tech, and more. Notable investments include companies like Ochre Bio, which focuses on developing RNA therapies for liver disease, and Nutropy, a biotech startup creating sustainable food products. The fund's investment strategy is geared towards achieving outsized returns by backing startups that push the boundaries of science and technology, particularly those with the potential to create significant societal impact. Beast Ventures offers flexible investment sizes, ranging from $100,000 to $2 million, and is known for its deep commitment to supporting cutting-edge innovation​.